<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:43:51Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6567574" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6567574</identifier>
        <datestamp>2019-06-17</datestamp>
        <setSpec>arthresther</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Arthritis Res Ther</journal-id>
              <journal-id journal-id-type="iso-abbrev">Arthritis Res. Ther</journal-id>
              <journal-title-group>
                <journal-title>Arthritis Research &amp; Therapy</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1478-6354</issn>
              <issn pub-type="epub">1478-6362</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6567574</article-id>
              <article-id pub-id-type="pmcid">PMC6567574</article-id>
              <article-id pub-id-type="pmc-uid">6567574</article-id>
              <article-id pub-id-type="pmid">31196179</article-id>
              <article-id pub-id-type="publisher-id">1923</article-id>
              <article-id pub-id-type="doi">10.1186/s13075-019-1923-x</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Haraden</surname>
                    <given-names>Collin A.</given-names>
                  </name>
                  <address>
                    <email>Collin.haraden@duke.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Huebner</surname>
                    <given-names>Janet L.</given-names>
                  </name>
                  <address>
                    <email>jhuebner@duke.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hsueh</surname>
                    <given-names>Ming-Feng</given-names>
                  </name>
                  <address>
                    <email>mingfeng.hsueh@duke.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Yi-Ju</given-names>
                  </name>
                  <address>
                    <email>yiju.li@duke.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8173-8258</contrib-id>
                  <name>
                    <surname>Kraus</surname>
                    <given-names>Virginia Byers</given-names>
                  </name>
                  <address>
                    <phone>919-681-6652</phone>
                    <email>vbk@duke.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution>Duke Molecular Physiology Institute, </institution><institution>Duke University School of Medicine, </institution></institution-wrap>Box 104775, 300 North Duke St, Durham, NC 27701 USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution>Department of Biostatistics and Bioinformatics, </institution><institution>Duke University School of Medicine, </institution></institution-wrap>Durham, NC USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution>Department of Medicine, </institution><institution>Duke University School of Medicine, </institution></institution-wrap>Durham, NC USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>13</day>
                <month>6</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>13</day>
                <month>6</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <year>2019</year>
              </pub-date>
              <volume>21</volume>
              <elocation-id>146</elocation-id>
              <history>
                <date date-type="received">
                  <day>15</day>
                  <month>2</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>22</day>
                  <month>5</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s). 2019</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">To identify a synovial fluid (SF) biomarker profile characteristic of individuals with an inflammatory osteoarthritis (OA) endotype.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">A total of 48 knees (of 25 participants) were characterized for an extensive array of SF biomarkers quantified by Rules Based Medicine using the high-sensitivity multiplex immunoassay, Myriad Human InflammationMAP® 1.0, which included 47 different cytokines, chemokines, and growth factors related to inflammation. Multivariable regression with generalized estimating equations (GEE) and false discovery rate (FDR) correction was used to assess associations of SF RBM biomarkers with etarfolatide imaging scores reflecting synovial inflammation; radiographic knee OA severity (based on Kellgren-Lawrence (KL) grade, joint space narrowing, and osteophyte scores); knee joint symptoms; and SF biomarkers associated with activated macrophages and knee OA progression including CD14 and CD163 (shed by activated macrophages) and elastase (shed by activated neutrophils).</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Significant associations of SF biomarkers meeting FDR &lt; 0.05 included soluble (s)VCAM-1 and MMP-3 with synovial inflammation (FDR-adjusted <italic>p</italic> = 0.025 and 1.06 × 10<sup>−7</sup>); sVCAM-1, sICAM-1, TIMP-1, and VEGF with radiographic OA severity (<italic>p</italic> = 1.85 × 10<sup>−5</sup> to 3.97 × 10<sup>−4</sup>); and VEGF, MMP-3, TIMP-1, sICAM-1, sVCAM-1, and MCP-1 with OA symptoms (<italic>p</italic> = 2.72 × 10<sup>−5</sup> to 0.050). All these SF biomarkers were highly correlated with macrophage markers CD163 and CD14 in SF (<italic>r</italic> = 0.43 to 0.90, FDR &lt; 0.05); all but MCP-1 were also highly correlated with neutrophil elastase in SF (<italic>r</italic> = 0.62 to 0.89, FDR &lt; 0.05).</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">A subset of six SF biomarkers was related to synovial inflammation in OA, as well as radiographic and symptom severity. These six OA-related SF biomarkers were specifically linked to indicators of activated macrophages and neutrophils. These results attest to an inflammatory OA endotype that may serve as the basis for therapeutic targeting of a subset of individuals at high risk for knee OA progression.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par5">Written informed consent was received from participants prior to inclusion in the study; the study was registered at ClinicalTrials.gov (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01237405">NCT01237405</ext-link>) on November 9, 2010, prior to enrollment of the first participant.</p>
                </sec>
                <sec>
                  <title>Electronic supplementary material</title>
                  <p>The online version of this article (10.1186/s13075-019-1923-x) contains supplementary material, which is available to authorized users.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Osteoarthritis</kwd>
                <kwd>Joint pain</kwd>
                <kwd>Macrophage</kwd>
                <kwd>Neutrophil</kwd>
                <kwd>Inflammation</kwd>
                <kwd>Biomarker</kwd>
                <kwd>Knee</kwd>
                <kwd>Severity</kwd>
                <kwd>Radiograph</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>NIH/NIA Claude D. Pepper OAIC</institution>
                  </funding-source>
                  <award-id>AG028716</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Kraus</surname>
                      <given-names>Virginia Byers</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2019</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par34">Although the role of inflammation in osteoarthritis (OA) has been heavily debated, cumulative evidence from ultrasound and magnetic resonance imaging (MRI) demonstrates inflammation in the majority of individuals with radiographic knee OA [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. Moreover, inflammation in the form of MRI effusion or Hoffa’s fat pad synovitis predict increased risk of incident radiographic knee OA [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Using 99mTc-etarfolatide nuclear imaging, we have detected a high frequency of folate receptor-positive cells (FR+), representing activated macrophages [<xref ref-type="bibr" rid="CR7">7</xref>] and neutrophils [<xref ref-type="bibr" rid="CR8">8</xref>], in knee OA.</p>
              <p id="Par35">Both macrophages and neutrophils respond to and perpetuate local inflammation. In response to damage-associated molecule patterns (DAMPs) and inflammatory cytokines, macrophages can become activated in the joint organ and modulate the local cytokine, growth factor, and matrix metalloproteinase (MMP) environment [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Neutrophils secrete a number of proteinases including elastase [<xref ref-type="bibr" rid="CR11">11</xref>] capable of degrading many targets including elastin, collagens, and proteoglycans [<xref ref-type="bibr" rid="CR12">12</xref>]. In addition, neutrophil elastase can upregulate the expression of proteinase-activated receptors (PARs) and activate them though cleavage [<xref ref-type="bibr" rid="CR13">13</xref>]. When activated, PARs perpetuate synovitis and cartilage loss and cause hyperalgesia and osteophyte formation [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p>
              <p id="Par36">We recently discovered that synovial fluid (SF) biomarkers CD14 and CD163, soluble forms of macrophage cell surface markers, and SF elastase, secreted by neutrophils [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], function as quantitative traits of the etarfolatide-positive phenotype and predict knee OA progression over 3 years [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Using the SF and plasma samples from individuals with knee OA, our goal in this substudy was to investigate the association of an extensive array of SF biomarkers with knee OA inflammation based on etarfolatide phenotyping, radiographic manifestations of knee OA, and OA symptoms. Patients were recruited for the original study on evidence of radiographic OA and symptoms and not inflammatory OA clinical signs. Thus, this substudy was designed to evaluate inflammation in “typical” OA joints. We hypothesized that the synovial fluid biomarkers associated with etarfolatide imaging and knee radiographic OA severity would provide a molecular biological profile for identifying the subset of subjects with an inflammatory OA endotype [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
            </sec>
            <sec id="Sec2">
              <title>Patients and methods</title>
              <sec id="Sec3">
                <title>Study description</title>
                <p id="Par37">This is a novel substudy of an investigator-initiated single-center clinical trial conducted at Duke University Medical Center performed as previously described [<xref ref-type="bibr" rid="CR7">7</xref>] and with authorization from the Food and Drug Administration (IND 108,677). The study was registered at <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> (NCT01237405) prior to enrollment of the first participant. Participants ≥18 years old were recruited on the basis of radiographic OA (Kellgren-Lawrence [<xref ref-type="bibr" rid="CR18">18</xref>] grade 1–4 severity) in at least one knee and knee pain in the index knee on most days of any 1 month in the last year [<xref ref-type="bibr" rid="CR19">19</xref>]. A total of 25 participants were enrolled. Exclusion criteria were as previously described [<xref ref-type="bibr" rid="CR7">7</xref>]. This clinical investigation was conducted according to the Declaration of Helsinki principles, with the approval of the Duke University Medical Center Institutional Review Board. Written informed consent was received from participants prior to inclusion in the study.</p>
              </sec>
              <sec id="Sec4">
                <title>Imaging</title>
                <p id="Par38">Knee radiographs (<italic>n</italic> = 50) of both knees of 25 patients were obtained as previously described using an optimal and standardized method with the SynaFlexer™ frame [<xref ref-type="bibr" rid="CR20">20</xref>]. Radiographs were graded blinded to other imaging and clinical data by the consensus of two experienced readers with high inter-rater reliability as previously described [<xref ref-type="bibr" rid="CR21">21</xref>]. Radiographs were scored for Kellgren-Lawrence (KL) [<xref ref-type="bibr" rid="CR18">18</xref>] grade (0–4), joint space narrowing (JSN, 0–3), and osteophyte severity (OST, 0–3) using a standard atlas [<xref ref-type="bibr" rid="CR22">22</xref>]. All 25 individuals also underwent Etarfolatide imaging of both knees and the whole body as previously described with high intra-rater reliability of scoring (<italic>κ</italic> = 0.68–0.90) [<xref ref-type="bibr" rid="CR7">7</xref>]. For these analyses, severity of synovitis due to the presence of cells positive for folate receptor, reflecting both activated macrophages and neutrophils, was quantified by summing synovial etarfolatide scores for medial and lateral compartments of the knee.</p>
              </sec>
              <sec id="Sec5">
                <title>Clinical symptoms</title>
                <p id="Par39">All 50 knees were scored semi-quantitatively (normal/none 0, mild 1, moderate 2, or severe 3) for self-reported intensity of joint pain ascertained by the NHANES I criterion [<xref ref-type="bibr" rid="CR19">19</xref>] (pain, aching or stiffness (PAS) on most days of any 1 month in the last year).</p>
              </sec>
              <sec id="Sec6">
                <title>Biospecimen collection</title>
                <p id="Par40">SF was collected from 48 knees either directly (<italic>n</italic> = 28) or by small volume (10 ml) saline lavage (<italic>n</italic> = 20) when direct aspiration failed. Two patients refused joint aspirations of their second knee. The dilution factor of SF obtained by small volume saline lavage was determined, and corresponding biomarker concentrations were corrected using a previously established urea-based methodology [<xref ref-type="bibr" rid="CR23">23</xref>]. Whole blood was obtained immediately after SF aspiration using Truculture Null (782–001086, RBM) tubes with subsequent manual separation of plasma supernatants from cells using valve filter Seraplas® V11 (53.677, Sarstedt). All samples were stored at − 80 °C until analysis.</p>
              </sec>
              <sec id="Sec7">
                <title>Biomarker quantification</title>
                <p id="Par41">Biomarkers in SF and plasma were quantified by Rules Based Medicine (RBM; Austin, TX) using the high-sensitivity multiplex immunoassay Myriad Human InflammationMAP® 1.0. Measured biomarkers included 47 different cytokines, chemokines, and growth factors related to inflammation. For purposes of statistical analyses, biomarkers were excluded if &gt; 25% of the samples had out-of-range low values; excluded biomarkers were brain-derived neurotropic factor (BDNF), C-reactive protein (CRP), eotaxin-1, granulocyte macrophage colony-stimulating factor (GM-CSF), interferon gamma (IFN), interleukin-1 beta (IL-1β), interleukin-2 (IL-2), interleukin-3 (IL-3), interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-7 (IL-7), interleukin-8 (IL-8), interleukin-10 (IL-10), interleukin-15 (IL-15), interleukin-17 (IL-17), interleukin-18 (IL-18), interleukin-23 (IL-23), interleukin-12 subunit p40 (IL-12p40), interleukin-12 subunit p70 (IL-12p70), macrophage inflammatory protein-1 alpha (MIP-1α), macrophage inflammatory protein-1 beta (MIP-1β), matrix metalloproteinase-2 (MMP-2), T-cell specific protein (RANTES), tumor necrosis factor alpha (TNFα), tumor necrosis factor beta (TNFβ), tumor necrosis factor receptor 1 (TNFR1), and von Willebrand factor (vWF).</p>
                <p id="Par42">A total of 17 SF biomarkers met inclusion criteria for statistical analysis. For retained biomarkers, out-of-range low concentrations were imputed as ½ the lower limit of detection (LLOD; <italic>n</italic> = 34 concentrations representing 4% of total determinations); out-of-range high values were imputed as twice the upper limit of detection (ULOD; <italic>n</italic> = 1 concentration representing 0.1% of total determinations). Intra- and inter-assay coefficients of variance for the retained biomarkers, as determined by RBM, were &lt; 7% and &lt; 15%, respectively (Table <xref rid="Tab1" ref-type="table">1</xref>). The mean and interquartile range of SF and plasma biomarker concentrations and the number outside limits of detection are reported in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Descriptive statistics for included biomarkers</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="4">Synovial fluid</th><th colspan="4">Plasma</th><th colspan="4"/></tr><tr><th>Biomarker</th><th><italic>N</italic></th><th><italic>N</italic> outside LOD</th><th>Mean</th><th>IQR</th><th><italic>N</italic></th><th><italic>N</italic> outside LOD</th><th>Mean</th><th>IQR</th><th>LLOD</th><th>Unit</th><th>Intra-assay CV (%)</th><th>Inter- assay CV (%)</th></tr></thead><tbody><tr><td>A2M</td><td>48</td><td>0</td><td>0.17</td><td>0.11</td><td>25</td><td>0</td><td>0.42</td><td>0.11</td><td>0.051</td><td>mg/mL</td><td>7.26</td><td>13.75</td></tr><tr><td>AAT</td><td>48</td><td>0</td><td>0.53</td><td>0.46</td><td>25</td><td>0</td><td>1.01</td><td>0.23</td><td>0.0065</td><td>mg/mL</td><td>4.93</td><td>9.33</td></tr><tr><td>B2M</td><td>47</td><td>1</td><td>1.10</td><td>0.90</td><td>25</td><td>0</td><td>0.76</td><td>0.27</td><td>0.15</td><td>μg/mL</td><td>3.83</td><td>6.33</td></tr><tr><td>C3</td><td>47</td><td>1</td><td>0.13</td><td>0.14</td><td>25</td><td>0</td><td>0.57</td><td>0.18</td><td>0.00065</td><td>mg/mL</td><td>5.87</td><td>7.33</td></tr><tr><td>Factor7</td><td>44</td><td>4</td><td>66.29</td><td>74.91</td><td>25</td><td>0</td><td>484.88</td><td>143.00</td><td>5.60</td><td>ng/mL</td><td>3.13</td><td>8.00</td></tr><tr><td>Fibrinogen</td><td>44</td><td>4</td><td>0.08</td><td>0.08</td><td>25</td><td>0</td><td>3.69</td><td>1.33</td><td>0.0056</td><td>mg/mL</td><td>5.47</td><td>10.67</td></tr><tr><td>FRTN</td><td>48</td><td>0</td><td>271.66</td><td>229.63</td><td>24</td><td>1</td><td>41.14</td><td>41.00</td><td>6.23</td><td>ng/mL</td><td>5.67</td><td>11.33</td></tr><tr><td>sICAM-1</td><td>46</td><td>2</td><td>21.55</td><td>20.52</td><td>25</td><td>0</td><td>55.30</td><td>17.50</td><td>4.78</td><td>ng/mL</td><td>3.60</td><td>8.33</td></tr><tr><td>IL-1ra</td><td>44</td><td>4</td><td>273.29</td><td>184.00</td><td>25</td><td>0</td><td>278.08</td><td>332.00</td><td>250.00</td><td>pg/mL</td><td>4.87</td><td>7.67</td></tr><tr><td>MCP-1</td><td>46</td><td>2</td><td>218.52</td><td>195.96</td><td>25</td><td>0</td><td>381.98</td><td>166.00</td><td>9.56</td><td>pg/mL</td><td>3.53</td><td>6.00</td></tr><tr><td>MMP-3</td><td>45</td><td>3</td><td>1.16 × 10<sup>6</sup></td><td>5.75 × 10<sup>5</sup></td><td>25</td><td>0</td><td>1.22 × 10<sup>4</sup></td><td>5.30 × 10<sup>3</sup></td><td>5.07 × 10<sup>3</sup></td><td>pg/mL</td><td>3.87</td><td>8.67</td></tr><tr><td>MMP-9</td><td>43</td><td>5</td><td>30.50</td><td>15.1</td><td>23</td><td>2</td><td>15.00</td><td>6.50</td><td>41.4</td><td>ng/mL</td><td>4.53</td><td>8.33</td></tr><tr><td>SCF</td><td>45</td><td>3</td><td>198.56</td><td>77.00</td><td>25</td><td>0</td><td>94.75</td><td>38.50</td><td>195.6</td><td>pg/mL</td><td>3.47</td><td>6.67</td></tr><tr><td>TIMP-1</td><td>48</td><td>0</td><td>177.44</td><td>201.05</td><td>25</td><td>0</td><td>37.14</td><td>16.80</td><td>9.575</td><td>ng/mL</td><td>3.80</td><td>10.00</td></tr><tr><td>sVCAM-1</td><td>45</td><td>3</td><td>292.10</td><td>290.80</td><td>25</td><td>0</td><td>282.36</td><td>90.00</td><td>4.265</td><td>ng/mL</td><td>6.60</td><td>14.00</td></tr><tr><td>VDBP</td><td>47</td><td>1</td><td>65.15</td><td>47.27</td><td>25</td><td>0</td><td>126.89</td><td>73.70</td><td>0.635</td><td>μg/mL</td><td>3.60</td><td>9.67</td></tr><tr><td>VEGF</td><td>46</td><td>2</td><td>778.06</td><td>873.36</td><td>25</td><td>0</td><td>188.80</td><td>45.00</td><td>18.14</td><td>pg/mL</td><td>4.13</td><td>8.00</td></tr></tbody></table><table-wrap-foot><p>Biomarkers listed yielded measurable values for ≥ 75% of samples</p><p><italic>Abbreviations</italic>: <italic>LOD</italic> limit of detection, <italic>IQR</italic> interquartile range, <italic>LLOD</italic> lower limit of detection, <italic>CV</italic> coefficient of variation, <italic>A2M</italic> alpha-2-macroglobulin, <italic>AAT</italic> alpha-1-antitrypsin, <italic>B2M</italic> beta-2-microglobulin, <italic>C3</italic> complement C3, <italic>FRTN</italic> ferritin, <italic>sICAM-1</italic> soluble intercellular adhesion molecule 1, <italic>IL-1ra</italic> interleukin-1 receptor antagonist, <italic>MCP-1</italic> monocyte chemotactic protein 1, <italic>MMP-3</italic> matrix metalloproteinase-3, <italic>MMP-9</italic> matrix metalloproteinase-9, <italic>SCF</italic> stem cell factor, <italic>TIMP-1</italic> tissue inhibitor of metalloproteinases 1, <italic>sVCAM-1</italic> soluble vascular cell adhesion molecule-1, <italic>VDBP</italic> vitamin D-binding protein, <italic>VEGF</italic> vascular endothelial growth factor</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec8">
                <title>Statistical analysis</title>
                <p id="Par43">We evaluated the association of SF and plasma biomarker concentrations with synovial inflammation (based on Etarfolatide imaging), radiographic OA severity and OA symptoms. Due to the inclusion of measurements from two knees of each patient, generalized estimating equations (GEE) were used to account for within-subject correlation using exchangeable variance-covariance matrix. The GEE model includes the main predictor of interest (the biomarker), age, gender, and body mass index (BMI) for each outcome of interest. False discovery rate (FDR) was computed using methodology described by Benjamini and Hochberg [<xref ref-type="bibr" rid="CR24">24</xref>]. Significant results were determined based on an FDR-adjusted <italic>p</italic> value ≤ 0.05. Significant SF RBM biomarkers from these analyses were further evaluated for correlation with SF CD14, SF CD163, and SF neutrophil elastase (measured previously on these samples as described [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]) using the Bland and Altman method (rmcorr package in R) to compute repeated measures correlation coefficients [<xref ref-type="bibr" rid="CR25">25</xref>]. For the correlation between SF and plasma biomarkers, we averaged SF biomarkers across both knees before computing Spearman correlations. These GEE, Bland and Altman correlations, and Spearman analyses were performed using R (<ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>). To determine if SF biomarker concentrations were statistically significantly higher than plasma (and therefore potentially of joint tissue origin), the plasma concentrations and the average SF biomarker concentration of both knees were evaluated with the one-sided Wilcoxon signed-rank test using JMP® Pro, Version 13 (SAS Institute Inc., Cary, NC). A protein functional association network plot was generated using STRING v10.5 database (<ext-link ext-link-type="uri" xlink:href="http://string-db.org">http://string-db.org</ext-link>) [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
              </sec>
            </sec>
            <sec id="Sec9">
              <title>Results</title>
              <sec id="Sec10">
                <title>Etarfolatide scan cohort</title>
                <p id="Par44">Participants (<italic>n</italic> = 25) were of mean age 62.4 ± 15.8 years (range 30–89), of mean BMI 29.2 ± 4.8 kg/m2 (range 22.5–38.4), and 72% female. The majority (76%) of participants had moderate to severe bilateral radiographic knee OA with 24% KL grade 1, 58% KL grade 2–3, and 18% KL grade 4.</p>
              </sec>
              <sec id="Sec11">
                <title>Association of synovial fluid biomarkers with severity of OA inflammation, structural features, and symptoms</title>
                <p id="Par45">Of the 17 biomarkers included for statistical analyses, MMP-3 and sVCAM-1 were associated with knee inflammation as assessed by etarfolatide imaging (FDR &lt; 0.05); sICAM-1 and TIMP-1 were marginally associated with inflammation (FDR = 0.090, 0.097). Five biomarkers (MMP-3, sVCAM-1, sICAM-1, TIMP-1, and VEGF) were associated with radiographic features of OA (FDR &lt; 0.05). These same five biomarkers plus MCP-1 were statistically significantly associated with OA symptoms (FDR &lt; 0.05) (Table <xref rid="Tab2" ref-type="table">2</xref>). Interestingly, MMP-3 was associated with JSN severity while sVCAM-1 was associated with both JSN and OST severity. Although SF VEGF was associated with both structural and symptom severity of OA (KL, JSN, OST, and OA symptom scores), it was not associated with inflammation as reflected by etarfolatide scores. MCP-1 was associated only with symptom severity.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Synovial fluid biomarkers associated with features of osteoarthritis (inflammation, radiographic, and symptom severity)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th>Etarfolatide imaging</th><th colspan="3">Radiographic severity</th><th>Symptom severity</th></tr><tr><th>Synovial inflammation</th><th>KL</th><th>JSN</th><th>OST</th><th>PAS</th></tr><tr><th>Biomarker</th><th>Est. ×10<sup>−2</sup> (95% CI)<break/>(pval)</th><th>Est. ×10<sup>−2</sup> (95% CI)<break/>(pval)</th><th>Est. ×10<sup>−2</sup> (95% CI)<break/>(pval)</th><th>Est. ×10<sup>−2</sup> (95% CI)<break/>(pval)</th><th>Est. ×10<sup>−2</sup> (95% CI)<break/>(pval)</th></tr></thead><tbody><tr><td>sVCAM-1</td><td><p>0.970 (0.330–1.610)</p><p><italic>(0.0029)</italic></p></td><td><p>0.160 (0.094–0.220)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.130 (0.052–0.002)</p><p><italic>(0.0009)</italic></p></td><td><p>0.430 (0.170–0.680)</p><p><italic>(0.0010)</italic></p></td><td><p>0.320 (0.120–0.510)</p><p><italic>(0.0015)</italic></p></td></tr><tr><td>MMP-3</td><td><p>52.712 (34.933–70.492)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>9.591 (5.289–13.982<italic>)</italic></p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>6.477 (2.962–9.994)</p><p><italic>(0.0003)</italic></p></td><td><p>17.695 (− 4.989–40.378)</p><p>(0.1263)</p></td><td><p>15.220 (7.567–22.872)</p><p><italic>(&lt; 0.0001)</italic></p></td></tr><tr><td>sICAM-1</td><td><p>16.120 (3.020–29.220)</p><p>(0.0159)</p></td><td>2.520 (1.400–3.630) <italic>(&lt; 0.0001)</italic></td><td><p>2.270 (0.970–3.570)</p><p><italic>(0.0006)</italic></p></td><td><p>6.510 (3.250–9.780)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>5.980 (2.480–9.480)</p><p><italic>(0.0008)</italic></p></td></tr><tr><td>TIMP-1</td><td><p>1.470 (0.200–2.740)</p><p>(0.0228)</p></td><td><p>0.200 (0.110–0.300)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.140 (0.070–0.220)</p><p><italic>(0.0002)</italic></p></td><td><p>0.610 (0.430–0.800)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.790 (0.400–1.190)</p><p><italic>(&lt; 0.0001)</italic></p></td></tr><tr><td>VEGF</td><td><p>0.076 (− 0.310–0.460)</p><p>(0.6985)</p></td><td><p>0.100 (0.047–0.140)</p><p><italic>(0.0001)</italic></p></td><td><p>0.070 (0.013–0.130)</p><p><italic>(0.0160)</italic></p></td><td><p>0.250 (0.120–0.370)</p><p><italic>(0.0001)</italic></p></td><td><p>0.210 (0.130–0.300)</p><p><italic>(&lt; 0.0001)</italic></p></td></tr><tr><td>MCP-1</td><td><p>0.470 (− 0.670–1.610)</p><p>(0.4159)</p></td><td><p>0.044(− 0.130–0.220)</p><p>(0.6207)</p></td><td><p>0.036 (− 0.120–0.190)</p><p>(0.6529)</p></td><td><p>0.310 (− 0.210–0.820)</p><p>(0.2410)</p></td><td><p>0.420 (0.073 – 0.760)</p><p><italic>(0.0175)</italic></p></td></tr></tbody></table><table-wrap-foot><p>Estimates (Est × 10<sup>−2</sup>) of regression coefficient (Beta estimate), 95% confidence intervals, and raw <italic>p</italic> values are listed in the table; those meeting FDR &lt; 0.05 are italicized</p><p><italic>Abbreviations</italic>: <italic>KL</italic> Kellgren-Lawrence; <italic>JSN</italic> joint space narrowing; <italic>OST</italic> osteophyte; <italic>PAS</italic> pain, aching and stiffness of knee; <italic>pval p</italic> value; <italic>CI</italic> confidence interval; <italic>sVCAM-1</italic> soluble vascular cell adhesion molecule 1; <italic>MMP-3</italic> matrix metalloproteinase-3; <italic>sICAM-1</italic> soluble intracellular adhesion molecule 1; <italic>TIMP-1</italic> tissue inhibitor of metallopeptidase inhibitor 1; <italic>VEGF</italic> vascular endothelial growth factor; <italic>MCP-1</italic> monocyte chemoattractant protein 1</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec12">
                <title>Correlations of synovial fluid biomarker concentrations with macrophage and neutrophil specific biomarkers</title>
                <p id="Par46">SF sVCAM-1, MMP-3, sICAM-1, TIMP-1, VEGF, and MCP-1 all correlated with markers specific for neutrophils (SF neutrophil elastase) and/or macrophages (SF CD14 and SF CD163) previously shown to predict knee OA progression [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] (Table <xref rid="Tab3" ref-type="table">3</xref>). These results suggest that this six-member panel of biomarkers reflects both macrophage- and neutrophil-mediated inflammation.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Correlations of synovial fluid RBM biomarkers with known osteoarthritis progression biomarkers</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">OA Progression Biomarkers</th><th colspan="6">Subset of synovial fluid RBM biomarkers associated with features of knee osteoarthritis*</th></tr><tr><th>sVCAM-1<break/><italic>r</italic> (95% CI)<break/>(pval)</th><th>MMP-3<break/><italic>r</italic> (95% CI)<break/>(pval)</th><th>sICAM-1<break/><italic>r</italic> (95% CI)<break/>(pval)</th><th>TIMP-1<break/><italic>r</italic> (95% CI)<break/>(pval)</th><th>VEGF<break/><italic>r</italic> (95% CI)<break/>(pval)</th><th>MCP-1<break/><italic>r</italic> (95% CI)<break/>(pval)</th></tr></thead><tbody><tr><td>CD14</td><td><p>0.86 (0.69–0.94)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.77 (0.50–0.91)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.84 (0.64–0.94)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.88 (0.72–0.95)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.90 (0.76–0.96)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.50 (0.08–0.76)</p><p><italic>(0.016)</italic></p></td></tr><tr><td>CD163</td><td><p>0.80 (0.56–0.92)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.78 (0.51–0.91)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.70 (0.37–0.88)</p><p><italic>(0.0004)</italic></p></td><td><p>0.85 (0.66–0.94)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.75 (0.44–0.90)</p><p><italic>(0.0001)</italic></p></td><td><p>0.43 (− 0.02–0.73)</p><p><italic>(0.046)</italic></p></td></tr><tr><td>Neutrophil Elastase</td><td><p>0.88 (0.68–0.96)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.88 (0.68–0.96)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.87 (0.64–0.96)</p><p>(<italic>&lt; 0.0001</italic>)</p></td><td><p>0.89 (0.71–0.97)</p><p><italic>(&lt; 0.0001)</italic></p></td><td><p>0.62 (0.16–0.86)</p><p><italic>(0.008)</italic></p></td><td><p>0.14 (− 0.40–0.61)</p><p>(0.581)</p></td></tr></tbody></table><table-wrap-foot><p>*As shown in Table <xref rid="Tab2" ref-type="table">2</xref>; italicized <italic>p</italic> values pass FDR &lt; 0.05; <italic>r</italic> = repeated measures correlation coefficient by Bland and Altman method implemented in rmcorr</p><p><italic>Abbreviations</italic>: <italic>RBM</italic> Rules Based Medicine, <italic>pval p</italic> value, <italic>CI</italic> confidence interval, <italic>sVCAM-1</italic> soluble vascular cell adhesion molecule 1, <italic>MMP-3</italic> matrix metalloproteinase-3, <italic>sICAM-1</italic> soluble intracellular adhesion molecule 1, <italic>TIMP-1</italic> tissue inhibitor of metallopeptidase inhibitor 1, <italic>VEGF</italic> vascular endothelial growth factor, <italic>MCP-1</italic> monocyte chemoattractant protein 1</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec13">
                <title>Assessment of potential origin of biomarkers</title>
                <p id="Par47">Although plasma biomarker concentrations were not associated with any OA severity outcome, concentrations of one plasma biomarker, VEGF, correlated with its corresponding SF concentrations (Spearman’s rho <italic>p</italic> value ≤ 0.05, Additional file <xref rid="MOESM1" ref-type="media">1</xref>). Interestingly, plasma concentrations of VEGF also correlated with SF concentrations (averaged across both knees) of the other five inflammation associated biomarkers (sICAM-1, MCP-1, MMP-3, TIMP-1, and sVCAM-1). In addition, plasma MMP-3 correlated with SF concentrations of sVCAM-1. SF concentrations of VEGF, MMP-3, and TIMP-1 were all statistically significantly higher than the corresponding plasma concentrations (Additional file <xref rid="MOESM2" ref-type="media">2</xref>). Taken together, these results suggest that plasma VEGF may originate from the joint and reflect SF concentrations.</p>
              </sec>
              <sec id="Sec14">
                <title>Interactions of biomarkers associated with severity of OA inflammation, structural features, and symptoms</title>
                <p id="Par48">We utilized STRING [<xref ref-type="bibr" rid="CR26">26</xref>] to generate a functional protein association network for the six SF biomarkers (MMP-3, sVCAM-1, sICAM-1, VEGF, TIMP-1, and MCP-1) in this study with significant associations with etarfolatide (inflammation), KL (radiographic severity), and OA symptom scores. We added SF CD14, SF CD163, and SF neutrophil elastase to the model as biomarker surrogates for inflammation as we previously showed them to be strongly associated with the presence of folate receptor-positive cells in knee joints using etarfolatide imaging, strongly predictive of knee OA progression [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], and correlated with the OA-related RBM markers of the final panel. Relevant biological pathways strongly associated with these nine biomarkers include leukocyte migration and extracellular matrix organization (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). This plot is consistent with these biomarkers functioning both as extracellular signaling molecules and as effectors of OA progression.<fig id="Fig1"><label>Fig. 1</label><caption><p>STRING plot showing functional biomarker interrelationships. Depicted relationships represent biomarkers with significant associations with OA inflammation, radiographic OA, and OA symptoms analyzed using the STRING v10.5 database. The colors of the spheres correspond to the biological processes in which a particular biomarker is involved. Sphere color key: leukocyte migration (red), extracellular matrix organization (blue), and inflammatory response (green). Joining string color key (corresponding to origin of data used for STRING database): curated databases (blue), experimentally determined (pink), textmining (yellow), and co-expression (black). Abbreviations: CD, cluster of differentiation 14; CD163, cluster of differentiation 163; CCL2 (also referred to as MCP-1 or monocyte chemoattractant protein 1), C-C chemokine motif 2 vascular cell adhesion molecule 1; ELANE, neutrophil elastase; ICAM-1, intracellular adhesion molecule 1; MMP-3, matrix metalloproteinase-3; TIMP-1, tissue inhibitor of metallopeptidase inhibitor 1; VEGF, vascular endothelial growth factor</p></caption><graphic xlink:href="13075_2019_1923_Fig1_HTML" id="MO1"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec15">
              <title>Discussion</title>
              <p id="Par49">MMP-3, sVCAM-1, sICAM-1, VEGF, TIMP-1, and MCP-1 were all associated with synovial inflammation by etarfolatide imaging, radiographic OA severity, and/or OA symptoms. Although soluble VCAM-1, sICAM-1, and VEGF have no known intrinsic ability to cause cartilage loss, they were strongly associated with severity of cartilage loss based on JSN and macrophage and neutrophil markers (SF CD14, SF CD163, and SF elastase) that we found previously to be associated with OA progression [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Etarfolatide imaging, indicating the presence of activated macrophages and neutrophils in the synovial tissue [<xref ref-type="bibr" rid="CR8">8</xref>], provided additional in vivo evidence for synovial inflammation that was positively associated with SF biomarkers MMP-3 and sVCAM-1. These results are consistent with the inflammation and arthritis promoting roles of these molecules (summarized in Fig. <xref rid="Fig2" ref-type="fig">2</xref>) [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR37">37</xref>]. In particular, VCAM-1 is expressed by all cell types of the joint organ, chondrocytes, synovial fibroblasts, and adipocytes. Because VCAM-1 binds leukocytes [<xref ref-type="bibr" rid="CR35">35</xref>], soluble VCAM-1 serves as a chemotactic stimulus for macrophages [<xref ref-type="bibr" rid="CR36">36</xref>], and DAMPS and MCP-1 serve as chemotactic stimuli for macrophages and neutrophils [<xref ref-type="bibr" rid="CR38">38</xref>], thereby providing direct means for macrophages and neutrophils to home to the joint to promote cartilage degradation.<fig id="Fig2"><label>Fig. 2</label><caption><p>Inflammatory OA endotype based on synovial fluid biomarkers. This plot conceptualizes our data in the context of the current understanding of inflammation in OA. Abbreviations: OA, osteoarthritis; DAMPs, disease-associated molecular patterns; VCAM-1, vascular cell adhesion molecule 1; MMP-3, matrix metalloproteinase-3; ICAM-1, intracellular adhesion molecule 1; TLR, toll-like receptor; TIMP-1, tissue inhibitor of metallopeptidase inhibitor 1; VEGF, vascular endothelial growth factor; MCP-1, monocyte chemoattractant protein 1; KL, Kellgren-Lawrence; JSN, joint space narrowing; OST, osteophyte; NHANES, national health and nutrition examination survey measure of OA symptoms (pain, aching, stiffness)</p></caption><graphic xlink:href="13075_2019_1923_Fig2_HTML" id="MO2"/></fig></p>
              <p id="Par50">Of the six biomarkers, MMP-3, VEGF, and TIMP-1 were more abundant in SF than plasma supporting a joint tissue origin. The finding that SF, but not plasma biomarkers, correlated with OA severity outcomes, taken together with existing literature on these analytes in OA, further supports the concept that these markers are specific to local disease-related phenomena in the joint organ [<xref ref-type="bibr" rid="CR39">39</xref>]. For instance, MMP-3, a well-known collagen degrading protease associated with OA progression [<xref ref-type="bibr" rid="CR29">29</xref>], is known to contribute to cartilage breakdown with the generation of DAMPs [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. These DAMPs can directly activate macrophages and neutrophils [<xref ref-type="bibr" rid="CR33">33</xref>] and increase synovial inflammation through toll-like receptor signaling [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. VEGF is a signal protein of angiogenesis that can increase inflammation through creation of blood vessels capable of leukocyte recruitment [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. VEGF injected into the temporomandibular joint increased MMP-9, MMP-13, the initiation of OA, and cartilage loss [<xref ref-type="bibr" rid="CR42">42</xref>]. VEGF inhibition, in surgically induced (destabilization of medial meniscus) OA, reduced OA progression [<xref ref-type="bibr" rid="CR43">43</xref>]. VEGF also acts as a chemoattractant and activator of macrophages [<xref ref-type="bibr" rid="CR44">44</xref>]. Once macrophages are recruited to the joint, they have the ability to produce more VEGF and promote further angiogenesis, symptoms [<xref ref-type="bibr" rid="CR45">45</xref>], and synovitis that will facilitate macrophage recruitment and perpetuate joint inflammation [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
              <p id="Par51">Although the hallmarks of osteoarthritis, OA pain, aching, and stiffness, are highly heterogeneous, a major contributor to OA symptoms is synovitis [<xref ref-type="bibr" rid="CR29">29</xref>]. It is therefore understandable that synovial fluid biomarkers shown here (sVCAM-1, MMP-3, sICAM-1, VEGF, TIMP-1) and previously (CD14) to be associated with synovial inflammation (as reflected by etarfolatide imaging scores) [<xref ref-type="bibr" rid="CR16">16</xref>] were also associated with joint pain, aching, and stiffness. These markers may therefore have value as indicators of a symptomatic inflammatory OA endotype. These results are in agreement with previous studies showing that sVCAM-1 and sICAM-1 are associated with synovitis [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Moreover, VEGF can also lead to cartilage vascularization at sites that subsequently form osteophytes [<xref ref-type="bibr" rid="CR47">47</xref>]; osteophytes are a feature of OA known to contribute to symptoms [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
              <p id="Par52">Limitations of this study include the small cohort size, especially in comparison to the number of outcomes measured. However, to mitigate this limitation, multiple measures correction was performed by adjusting <italic>p</italic> values using the Benjamini-Hochberg false discovery rate [<xref ref-type="bibr" rid="CR24">24</xref>] method. Due to the cross-sectional analysis and absence of longitudinal data, causality of biomarkers with OA progression could not be inferred. Although we do not have longitudinal data, several of these biomarkers have face validity for involvement in OA progression based on the literature including VEGF, ICAM1, VCAM1, and MMP3 [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR51">51</xref>]. When direct aspiration of SF failed, low volume saline lavage was performed. Using both direct and lavage SF in this study is both a strength and a limitation. On the one hand, this is a strategy that allows potential evaluation of the highest number of knees, even less inflamed ones without appreciable SF; on the other hand, the knees requiring lavage tend to be less inflamed, having lower inflammatory biomarker concentrations that are even lower with lavage. As expected, more biomarker concentrations from lavage samples were below lower limits of detection of the inflammation map multiplex assays. Nevertheless, we were partially able to overcome these challenges with biomarker selection criteria, the well-established urea correction method [<xref ref-type="bibr" rid="CR23">23</xref>] and a well-established imputation methodology. Although only 17 of 47 SF biomarkers passed our inclusion criteria for statistical analysis, the biological credibility of the results attests to the viability of this strategy.</p>
            </sec>
            <sec id="Sec16">
              <title>Conclusions</title>
              <p id="Par53">In summary, this study provides support for an inflammatory knee OA endotype characterized by the presence in the synovium of activated macrophages and neutrophils and their association with SF biomarkers of inflammation and angiogenesis. These data support a highly integrated process with VEGF, a biomarker of angiogenesis [<xref ref-type="bibr" rid="CR37">37</xref>], increasing expression of MMPs and inflammation, based on markers of vascular adhesion, sVCAM-1 and sICAM-1, correlated with synovitis [<xref ref-type="bibr" rid="CR36">36</xref>]. This biomarker profile may assist in identifying a specific subgroup of patients for treatments modulating inflammation and activated macrophages and neutrophils.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Additional files</title>
              <sec id="Sec17">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="13075_2019_1923_MOESM1_ESM.docx">
                      <label>Additional file 1:</label>
                      <caption>
                        <p>Correlation of biomarkers in plasma with synovial fluid. SF biomarkers were correlated to corresponding plasma biomarkers using Spearman correlation. (DOCX 16 kb)</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="13075_2019_1923_MOESM2_ESM.docx">
                      <label>Additional file 2:</label>
                      <caption>
                        <p>Wilcoxon signed ranks for SF vs. plasma. Wilcoxon signed-rank statistic shows whether the biomarker was higher in SF or plasma. (DOCX 13 kb)</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>A2M</term>
                  <def>
                    <p id="Par6">Alpha-2-Macroglobulin</p>
                  </def>
                </def-item>
                <def-item>
                  <term>AAT</term>
                  <def>
                    <p id="Par7">Alpha-1-Antitrypsin</p>
                  </def>
                </def-item>
                <def-item>
                  <term>B2M</term>
                  <def>
                    <p id="Par8">Beta-2-Microglobulin</p>
                  </def>
                </def-item>
                <def-item>
                  <term>C3</term>
                  <def>
                    <p id="Par9">Complement C3</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CV</term>
                  <def>
                    <p id="Par10">Coefficient of Variation</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DAMPs</term>
                  <def>
                    <p id="Par11">Damage-associated molecule patterns</p>
                  </def>
                </def-item>
                <def-item>
                  <term>FRTN</term>
                  <def>
                    <p id="Par12">Ferritin</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GEE</term>
                  <def>
                    <p id="Par13">Generalized estimating equations</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ICAM-1</term>
                  <def>
                    <p id="Par14">Intercellular adhesion molecule 1</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IL-1ra</term>
                  <def>
                    <p id="Par15">Interleukin-1 receptor antagonist</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IQR</term>
                  <def>
                    <p id="Par16">Interquartile range</p>
                  </def>
                </def-item>
                <def-item>
                  <term>JSN</term>
                  <def>
                    <p id="Par17">Joint space narrowing</p>
                  </def>
                </def-item>
                <def-item>
                  <term>KL</term>
                  <def>
                    <p id="Par18">Kellgren-Lawrence</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LLOD</term>
                  <def>
                    <p id="Par19">Lower limit of detection</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MCP-1</term>
                  <def>
                    <p id="Par20">Monocyte chemotactic protein 1</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MMP</term>
                  <def>
                    <p id="Par21">Matrix metalloproteinase</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MMP-3</term>
                  <def>
                    <p id="Par22">Matrix metalloproteinase-3</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MMP-9</term>
                  <def>
                    <p id="Par23">Matrix metalloproteinase-9</p>
                  </def>
                </def-item>
                <def-item>
                  <term>OA</term>
                  <def>
                    <p id="Par24">Osteoarthritis</p>
                  </def>
                </def-item>
                <def-item>
                  <term>OST</term>
                  <def>
                    <p id="Par25">Osteophyte</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PARs</term>
                  <def>
                    <p id="Par26">Proteinase-activated receptors</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SCF</term>
                  <def>
                    <p id="Par27">Stem cell factor</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SF</term>
                  <def>
                    <p id="Par28">Synovial fluid</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TIMP-1</term>
                  <def>
                    <p id="Par29">Tissue inhibitor of metalloproteinases 1</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ULOD</term>
                  <def>
                    <p id="Par30">Upper limit of detection</p>
                  </def>
                </def-item>
                <def-item>
                  <term>VCAM-1</term>
                  <def>
                    <p id="Par31">Vascular cell adhesion molecule-1</p>
                  </def>
                </def-item>
                <def-item>
                  <term>VDBP</term>
                  <def>
                    <p id="Par32">Vitamin D-binding protein</p>
                  </def>
                </def-item>
                <def-item>
                  <term>VEGF</term>
                  <def>
                    <p id="Par33">Vascular endothelial growth factor</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ack>
              <title>Acknowledgements</title>
              <p>We wish to acknowledge Dr. Peter Mitchell for his assistance with the study design and funding of the original etarfolatide cohort study.</p>
              <sec id="FPar1">
                <title>Funding</title>
                <p id="Par54">This study was funded in part by NIH/NIA Claude D. Pepper OAIC AG028716. The original cohort and biomarker analyses were funded by Eli Lilly and Co. Dr. Peter Mitchell, then at Eli Lilly and Co, assisted with the design of the original study. The funding bodies had no role in the collection, analysis or interpretation of data or in writing the manuscript.</p>
              </sec>
              <sec id="FPar2" sec-type="data-availability">
                <title>Availability of data and materials</title>
                <p id="Par55">The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
              </sec>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>CAH drafted the manuscript and assisted with statistical analyses. JLH was involved with the study design, provided sample handling, and assisted with statistical analyses and data interpretation. MFH generated the neutrophil elastase data. YJL performed and supervised all the statistical analyses. VBK designed and supervised all aspects of the study. All authors participated in manuscript editing. All authors read and approved the final manuscript.</p>
            </notes>
            <notes>
              <title>Ethics approval and consent to participate</title>
              <p id="Par56">This clinical investigation was conducted according to Declaration of Helsinki principles, with the approval of the Duke University Medical Center Institutional Review Board. Written informed consent was received from participants prior to inclusion in the study.</p>
            </notes>
            <notes>
              <title>Consent for publication</title>
              <p id="Par57">Not applicable.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par58">The authors declare that they have no competing interests.</p>
            </notes>
            <notes>
              <title>Publisher’s Note</title>
              <p id="Par59">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Walther</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Harms</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Krenn</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Radke</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Faehndrich</surname>
                      <given-names>T-P</given-names>
                    </name>
                    <name>
                      <surname>Gohlke</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis</article-title>
                  <source>Arthritis Rheum</source>
                  <year>2001</year>
                  <volume>44</volume>
                  <issue>2</issue>
                  <fpage>331</fpage>
                  <lpage>338</lpage>
                  <pub-id pub-id-type="doi">10.1002/1529-0131(200102)44:2&lt;331::AID-ANR50&gt;3.0.CO;2-0</pub-id>
                  <pub-id pub-id-type="pmid">11229463</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Abraham</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Goff</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Pearce</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Francis</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Birrell</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Reliability and validity of ultrasound imaging of features of knee osteoarthritis in the community</article-title>
                  <source>BMC Musculoskelet Disord</source>
                  <year>2011</year>
                  <volume>12</volume>
                  <fpage>70</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2474-12-70</pub-id>
                  <pub-id pub-id-type="pmid">21470410</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Loeuille</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Chary-Valckenaere</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Champigneulle</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rat</surname>
                      <given-names>A-C</given-names>
                    </name>
                    <name>
                      <surname>Toussaint</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Pinzano-Watrin</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity</article-title>
                  <source>Arthritis Rheum</source>
                  <year>2005</year>
                  <volume>52</volume>
                  <issue>11</issue>
                  <fpage>3492</fpage>
                  <lpage>3501</lpage>
                  <pub-id pub-id-type="doi">10.1002/art.21373</pub-id>
                  <pub-id pub-id-type="pmid">16255041</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Østergaard</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Stoltenberg</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Løvgreen-Nielsen</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Volck</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Jensen Claus</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Lorenzen</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis. Comparison with the macroscopic and microscopic appearance of the synovium</article-title>
                  <source>Arthritis Rheum</source>
                  <year>2005</year>
                  <volume>40</volume>
                  <issue>10</issue>
                  <fpage>1856</fpage>
                  <lpage>1867</lpage>
                  <pub-id pub-id-type="doi">10.1002/art.1780401020</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yusuf</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Kortekaas</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Watt</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Huizinga</surname>
                      <given-names>TWJ</given-names>
                    </name>
                    <name>
                      <surname>Kloppenburg</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review</article-title>
                  <source>Ann Rheum Dis</source>
                  <year>2011</year>
                  <volume>70</volume>
                  <issue>1</issue>
                  <fpage>60</fpage>
                  <pub-id pub-id-type="doi">10.1136/ard.2010.131904</pub-id>
                  <pub-id pub-id-type="pmid">20829200</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Atukorala</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Kwoh</surname>
                      <given-names>CK</given-names>
                    </name>
                    <name>
                      <surname>Guermazi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Roemer</surname>
                      <given-names>FW</given-names>
                    </name>
                    <name>
                      <surname>Boudreau</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Hannon</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Synovitis in knee osteoarthritis: a precursor of disease?</article-title>
                  <source>Ann Rheum Dis</source>
                  <year>2016</year>
                  <volume>75</volume>
                  <issue>2</issue>
                  <fpage>390</fpage>
                  <pub-id pub-id-type="doi">10.1136/annrheumdis-2014-205894</pub-id>
                  <pub-id pub-id-type="pmid">25488799</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kraus</surname>
                      <given-names>VB</given-names>
                    </name>
                    <name>
                      <surname>McDaniel</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Huebner</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Stabler</surname>
                      <given-names>TV</given-names>
                    </name>
                    <name>
                      <surname>Pieper</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Shipes</surname>
                      <given-names>SW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Direct in vivo evidence of activated macrophages in human osteoarthritis</article-title>
                  <source>Osteoarthr Cartil</source>
                  <year>2016</year>
                  <volume>24</volume>
                  <issue>9</issue>
                  <fpage>1613</fpage>
                  <lpage>1621</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joca.2016.04.010</pub-id>
                  <pub-id pub-id-type="pmid">27084348</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hsueh</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wellman</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Bolognesi</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Kraus</surname>
                      <given-names>VB</given-names>
                    </name>
                  </person-group>
                  <article-title>Functional folate receptor cell-associated inflammatory cytokines predict the progression of knee osteoarthritis</article-title>
                  <source>Osteoarthr Cartil</source>
                  <year>2018</year>
                  <volume>26</volume>
                  <fpage>S121</fpage>
                  <lpage>S1S2</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joca.2018.02.266</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Blom</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>van Lent</surname>
                      <given-names>PLEM</given-names>
                    </name>
                    <name>
                      <surname>Holthuysen</surname>
                      <given-names>AEM</given-names>
                    </name>
                    <name>
                      <surname>van der Kraan</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Roth</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>van Rooijen</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis</article-title>
                  <source>Osteoarthr Cartil</source>
                  <year>2004</year>
                  <volume>12</volume>
                  <issue>8</issue>
                  <fpage>627</fpage>
                  <lpage>635</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joca.2004.03.003</pub-id>
                  <pub-id pub-id-type="pmid">15262242</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>W-C</given-names>
                    </name>
                    <name>
                      <surname>Sala-Newby</surname>
                      <given-names>GB</given-names>
                    </name>
                    <name>
                      <surname>Susana</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Newby</surname>
                      <given-names>AC</given-names>
                    </name>
                  </person-group>
                  <article-title>Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κB</article-title>
                  <source>PLoS One</source>
                  <year>2012</year>
                  <volume>7</volume>
                  <issue>8</issue>
                  <fpage>e42507</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0042507</pub-id>
                  <pub-id pub-id-type="pmid">22880008</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Korkmaz</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Horwitz</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Jenne</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Gauthier</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases</article-title>
                  <source>Pharmacol Rev</source>
                  <year>2010</year>
                  <volume>62</volume>
                  <issue>4</issue>
                  <fpage>726</fpage>
                  <pub-id pub-id-type="doi">10.1124/pr.110.002733</pub-id>
                  <pub-id pub-id-type="pmid">21079042</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muley</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Krustev</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Reid</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>McDougall</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Prophylactic inhibition of neutrophil elastase prevents the development of chronic neuropathic pain in osteoarthritic mice</article-title>
                  <source>J Neuroinflammation</source>
                  <year>2017</year>
                  <volume>14</volume>
                  <issue>1</issue>
                  <fpage>168</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12974-017-0944-0</pub-id>
                  <pub-id pub-id-type="pmid">28835277</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhou</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Perelman</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Kolosov</surname>
                      <given-names>VP</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>X</given-names>
                    </name>
                  </person-group>
                  <article-title>Neutrophil elastase induces MUC5AC secretion via protease-activated receptor 2</article-title>
                  <source>Mol Cell Biochem</source>
                  <year>2013</year>
                  <volume>377</volume>
                  <issue>1</issue>
                  <fpage>75</fpage>
                  <lpage>85</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11010-013-1572-3</pub-id>
                  <pub-id pub-id-type="pmid">23392769</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Russell</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>McDougall</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation</article-title>
                  <source>Inflamm Res</source>
                  <year>2009</year>
                  <volume>58</volume>
                  <issue>3</issue>
                  <fpage>119</fpage>
                  <lpage>126</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00011-009-8087-0</pub-id>
                  <pub-id pub-id-type="pmid">19184346</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huesa</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ortiz</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Dunning</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>McGavin</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Bennett</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>McIntosh</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <source>Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology. Annals of the Rheumatic Diseases</source>
                  <year>2016</year>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Daghestani</surname>
                      <given-names>HN</given-names>
                    </name>
                    <name>
                      <surname>Pieper</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Kraus</surname>
                      <given-names>VB</given-names>
                    </name>
                  </person-group>
                  <article-title>Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis</article-title>
                  <source>Arthritis Rheumatol</source>
                  <year>2015</year>
                  <volume>67</volume>
                  <issue>4</issue>
                  <fpage>956</fpage>
                  <lpage>965</lpage>
                  <pub-id pub-id-type="doi">10.1002/art.39006</pub-id>
                  <pub-id pub-id-type="pmid">25544994</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huebner</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Haraden</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>YJ</given-names>
                    </name>
                    <name>
                      <surname>Kraus</surname>
                      <given-names>VB</given-names>
                    </name>
                  </person-group>
                  <article-title>Biomarkers of macrophage-associated inflammatory pathways are associated with OA symptoms and radiographic disease</article-title>
                  <source>Osteoarthr Cartil</source>
                  <year>2018</year>
                  <volume>26</volume>
                  <fpage>S42</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.joca.2018.02.099</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kellgren</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Lawrence</surname>
                      <given-names>JS</given-names>
                    </name>
                  </person-group>
                  <article-title>Radiological assessment of osteo-arthrosis</article-title>
                  <source>Ann Rheum Dis</source>
                  <year>1957</year>
                  <volume>16</volume>
                  <issue>4</issue>
                  <fpage>494</fpage>
                  <lpage>502</lpage>
                  <pub-id pub-id-type="doi">10.1136/ard.16.4.494</pub-id>
                  <pub-id pub-id-type="pmid">13498604</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davis</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Ettinger</surname>
                      <given-names>WH</given-names>
                    </name>
                    <name>
                      <surname>Neuhaus</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Obesity and osteoarthritis of the knee: evidence from the National Health and Nutrition Examination Survey (NHANES I)</article-title>
                  <source>Semin Arthritis Rheum</source>
                  <year>1990</year>
                  <volume>20</volume>
                  <issue>3 Suppl 1</issue>
                  <fpage>34</fpage>
                  <lpage>41</lpage>
                  <pub-id pub-id-type="doi">10.1016/0049-0172(90)90045-H</pub-id>
                  <pub-id pub-id-type="pmid">2287947</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Charles</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Kraus</surname>
                      <given-names>VB</given-names>
                    </name>
                    <name>
                      <surname>Ainslie</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Hellio Le Graverand-Gastineau MP. Optimization of the fixed-flexion knee radiograph</article-title>
                  <source>Osteoarthr Cartil</source>
                  <year>2007</year>
                  <volume>15</volume>
                  <issue>11</issue>
                  <fpage>1221</fpage>
                  <lpage>1224</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joca.2007.05.012</pub-id>
                  <pub-id pub-id-type="pmid">17977754</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McDaniel</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Renner</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Sloane</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Kraus</surname>
                      <given-names>VB</given-names>
                    </name>
                  </person-group>
                  <article-title>Association of knee and ankle osteoarthritis with physical performance</article-title>
                  <source>Osteoarthr Cartil</source>
                  <year>2011</year>
                  <volume>19</volume>
                  <issue>6</issue>
                  <fpage>634</fpage>
                  <lpage>638</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joca.2011.01.016</pub-id>
                  <pub-id pub-id-type="pmid">21310252</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Altman</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>Gold</surname>
                      <given-names>GE</given-names>
                    </name>
                  </person-group>
                  <source>Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage</source>
                  <year>2007</year>
                  <fpage>A1</fpage>
                  <lpage>56</lpage>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kraus</surname>
                      <given-names>V.B.</given-names>
                    </name>
                    <name>
                      <surname>Stabler</surname>
                      <given-names>T.V.</given-names>
                    </name>
                    <name>
                      <surname>Kong</surname>
                      <given-names>S.Y.</given-names>
                    </name>
                    <name>
                      <surname>Varju</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>McDaniel</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Measurement of synovial fluid volume using urea</article-title>
                  <source>Osteoarthritis and Cartilage</source>
                  <year>2007</year>
                  <volume>15</volume>
                  <issue>10</issue>
                  <fpage>1217</fpage>
                  <lpage>1220</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joca.2007.03.017</pub-id>
                  <pub-id pub-id-type="pmid">17507255</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Benjamini</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Hochberg</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>
                  <source>J R Stat Soc Ser B</source>
                  <year>1995</year>
                  <volume>57</volume>
                  <fpage>289</fpage>
                  <lpage>300</lpage>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bland</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Altman</surname>
                      <given-names>DG</given-names>
                    </name>
                  </person-group>
                  <article-title>Calculating correlation coefficients with repeated observations: part 1--correlation within subjects</article-title>
                  <source>BMJ</source>
                  <year>1995</year>
                  <volume>310</volume>
                  <issue>6977</issue>
                  <fpage>446</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmj.310.6977.446</pub-id>
                  <pub-id pub-id-type="pmid">7873953</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Szklarczyk</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Franceschini</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wyder</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Forslund</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Heller</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Huerta-Cepas</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>STRING v10: protein–protein interaction networks, integrated over the tree of life</article-title>
                  <source>Nucleic Acids Res</source>
                  <year>2015</year>
                  <volume>43</volume>
                  <issue>Database issue</issue>
                  <fpage>D447</fpage>
                  <lpage>DD52</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gku1003</pub-id>
                  <pub-id pub-id-type="pmid">25352553</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pufe</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Petersen</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Tillmann</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Mentlein</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage</article-title>
                  <source>Arthritis Rheum</source>
                  <year>2001</year>
                  <volume>44</volume>
                  <issue>5</issue>
                  <fpage>1082</fpage>
                  <lpage>1088</lpage>
                  <pub-id pub-id-type="doi">10.1002/1529-0131(200105)44:5&lt;1082::AID-ANR188&gt;3.0.CO;2-X</pub-id>
                  <pub-id pub-id-type="pmid">11352239</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pfander</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Körtje</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Zimmermann</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Weseloh</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Kirsch</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Gesslein</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints</article-title>
                  <source>Ann Rheum Dis</source>
                  <year>2001</year>
                  <volume>60</volume>
                  <issue>11</issue>
                  <fpage>1070</fpage>
                  <pub-id pub-id-type="doi">10.1136/ard.60.11.1070</pub-id>
                  <pub-id pub-id-type="pmid">11602483</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sellam</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Berenbaum</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis</article-title>
                  <source>Nat Rev Rheumatol</source>
                  <year>2010</year>
                  <volume>6</volume>
                  <fpage>625</fpage>
                  <pub-id pub-id-type="doi">10.1038/nrrheum.2010.159</pub-id>
                  <pub-id pub-id-type="pmid">20924410</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ramos</surname>
                      <given-names>TN</given-names>
                    </name>
                    <name>
                      <surname>Bullard</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>Barnum</surname>
                      <given-names>SR</given-names>
                    </name>
                  </person-group>
                  <article-title>ICAM-1: isoforms and phenotypes</article-title>
                  <source>J Immunol</source>
                  <year>2014</year>
                  <volume>192</volume>
                  <issue>10</issue>
                  <fpage>4469</fpage>
                  <lpage>4474</lpage>
                  <pub-id pub-id-type="doi">10.4049/jimmunol.1400135</pub-id>
                  <pub-id pub-id-type="pmid">24795464</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schett</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Kiechl</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Bonora</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Zwerina</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Mayr</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Axmann</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints</article-title>
                  <source>Arthritis Rheum</source>
                  <year>2009</year>
                  <volume>60</volume>
                  <issue>8</issue>
                  <fpage>2381</fpage>
                  <lpage>2389</lpage>
                  <pub-id pub-id-type="doi">10.1002/art.24757</pub-id>
                  <pub-id pub-id-type="pmid">19644856</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miotla Zarebska</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Chanalaris</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Driscoll</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Burleigh</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>RE</given-names>
                    </name>
                    <name>
                      <surname>Malfait</surname>
                      <given-names>AM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>CCL2 and CCR2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy</article-title>
                  <source>Osteoarthr Cartil</source>
                  <year>2017</year>
                  <volume>25</volume>
                  <issue>3</issue>
                  <fpage>406</fpage>
                  <lpage>412</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joca.2016.10.008</pub-id>
                  <pub-id pub-id-type="pmid">27746376</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Tohme</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Al-Khafaji Ahmed</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Tai</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Loughran</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Damage-associated molecular pattern–activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury</article-title>
                  <source>Hepatology.</source>
                  <year>2015</year>
                  <volume>62</volume>
                  <issue>2</issue>
                  <fpage>600</fpage>
                  <lpage>614</lpage>
                  <pub-id pub-id-type="doi">10.1002/hep.27841</pub-id>
                  <pub-id pub-id-type="pmid">25855125</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sokolove</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lepus</surname>
                      <given-names>CM</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations</article-title>
                  <source>Therapeutic Adv Musculoskeletal Dis</source>
                  <year>2013</year>
                  <volume>5</volume>
                  <issue>2</issue>
                  <fpage>77</fpage>
                  <lpage>94</lpage>
                  <pub-id pub-id-type="doi">10.1177/1759720X12467868</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oertli</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Beck-Schimmer</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Fan</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Wüthrich</surname>
                      <given-names>RP</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-κB and activating protein-1</article-title>
                  <source>J Immunol</source>
                  <year>1998</year>
                  <volume>161</volume>
                  <issue>7</issue>
                  <fpage>3431</fpage>
                  <?supplied-pmid 9759861?>
                  <pub-id pub-id-type="pmid">9759861</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cook-Mills</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Marchese</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Abdala-Valencia</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants</article-title>
                  <source>Antioxid Redox Signal</source>
                  <year>2011</year>
                  <volume>15</volume>
                  <issue>6</issue>
                  <fpage>1607</fpage>
                  <lpage>1638</lpage>
                  <pub-id pub-id-type="doi">10.1089/ars.2010.3522</pub-id>
                  <pub-id pub-id-type="pmid">21050132</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koh</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>DiPietro</surname>
                      <given-names>LA</given-names>
                    </name>
                  </person-group>
                  <article-title>Inflammation and wound healing: the role of the macrophage</article-title>
                  <source>Expert Rev Mol Med</source>
                  <year>2011</year>
                  <volume>13</volume>
                  <fpage>e23</fpage>
                  <pub-id pub-id-type="doi">10.1017/S1462399411001943</pub-id>
                  <pub-id pub-id-type="pmid">21740602</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Petri</surname>
                      <given-names>Björn</given-names>
                    </name>
                    <name>
                      <surname>Sanz</surname>
                      <given-names>Maria-Jesús</given-names>
                    </name>
                  </person-group>
                  <article-title>Neutrophil chemotaxis</article-title>
                  <source>Cell and Tissue Research</source>
                  <year>2018</year>
                  <volume>371</volume>
                  <issue>3</issue>
                  <fpage>425</fpage>
                  <lpage>436</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00441-017-2776-8</pub-id>
                  <pub-id pub-id-type="pmid">29350282</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Likhodii</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Aref-Eshghi</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Harper</surname>
                      <given-names>PE</given-names>
                    </name>
                    <name>
                      <surname>Randell</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Relationship between blood plasma and synovial fluid metabolite concentrations in patients with osteoarthritis</article-title>
                  <source>J Rheumatol</source>
                  <year>2015</year>
                  <volume>42</volume>
                  <issue>5</issue>
                  <fpage>859</fpage>
                  <pub-id pub-id-type="doi">10.3899/jrheum.141252</pub-id>
                  <pub-id pub-id-type="pmid">25729031</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Foell</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Wittkowski</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Roth</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms of disease: a 'DAMP' view of inflammatory arthritis</article-title>
                  <source>Nat Clin Pract Rheumatol</source>
                  <year>2007</year>
                  <volume>3</volume>
                  <fpage>382</fpage>
                  <pub-id pub-id-type="doi">10.1038/ncprheum0531</pub-id>
                  <pub-id pub-id-type="pmid">17599072</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Mosser</surname>
                      <given-names>DM</given-names>
                    </name>
                  </person-group>
                  <article-title>Macrophage activation by endogenous danger signals</article-title>
                  <source>J Pathol</source>
                  <year>2008</year>
                  <volume>214</volume>
                  <issue>2</issue>
                  <fpage>161</fpage>
                  <lpage>178</lpage>
                  <pub-id pub-id-type="doi">10.1002/path.2284</pub-id>
                  <pub-id pub-id-type="pmid">18161744</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shen</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Jiao</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>WF</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>SY</given-names>
                    </name>
                    <name>
                      <surname>Qin</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Injecting vascular endothelial growth factor into the temporomandibular joint induces osteoarthritis in mice</article-title>
                  <source>Sci Rep</source>
                  <year>2015</year>
                  <volume>5</volume>
                  <fpage>16244</fpage>
                  <pub-id pub-id-type="doi">10.1038/srep16244</pub-id>
                  <pub-id pub-id-type="pmid">26531672</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nagao</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Kc</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Berendsen</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Duan</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Cheong</surname>
                      <given-names>CW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Vascular endothelial growth factor in cartilage development and osteoarthritis</article-title>
                  <source>Sci Rep</source>
                  <year>2017</year>
                  <volume>7</volume>
                  <issue>1</issue>
                  <fpage>13027</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-017-13417-w</pub-id>
                  <pub-id pub-id-type="pmid">29026147</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barleon</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Sozzani</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Weich</surname>
                      <given-names>HA</given-names>
                    </name>
                    <name>
                      <surname>Mantovani</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Marme</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1</article-title>
                  <source>Blood.</source>
                  <year>1996</year>
                  <volume>87</volume>
                  <issue>8</issue>
                  <fpage>3336</fpage>
                  <?supplied-pmid 8605350?>
                  <pub-id pub-id-type="pmid">8605350</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haywood</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>McWilliams</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>Pearson</surname>
                      <given-names>CI</given-names>
                    </name>
                    <name>
                      <surname>Gill</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Ganesan</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Inflammation and angiogenesis in osteoarthritis</article-title>
                  <source>Arthritis Rheum</source>
                  <year>2003</year>
                  <volume>48</volume>
                  <issue>8</issue>
                  <fpage>2173</fpage>
                  <lpage>2177</lpage>
                  <pub-id pub-id-type="doi">10.1002/art.11094</pub-id>
                  <pub-id pub-id-type="pmid">12905470</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Neogi</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Guermazi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Roemer</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Nevitt Michael</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Scholz</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Arendt-Nielsen</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Association of Joint Inflammation with pain sensitization in knee osteoarthritis: the multicenter Osteoarthritis Study</article-title>
                  <source>Arthritis Rheumatol</source>
                  <year>2015</year>
                  <volume>68</volume>
                  <issue>3</issue>
                  <fpage>654</fpage>
                  <lpage>661</lpage>
                  <pub-id pub-id-type="doi">10.1002/art.39488</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hashimoto</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Creighton-Achermann</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Takahashi</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Amiel</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Coutts</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>Lotz</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Development and regulation of osteophyte formation during experimental osteoarthritis</article-title>
                  <source>Osteoarthr Cartil</source>
                  <year>2002</year>
                  <volume>10</volume>
                  <issue>3</issue>
                  <fpage>180</fpage>
                  <lpage>187</lpage>
                  <pub-id pub-id-type="doi">10.1053/joca.2001.0505</pub-id>
                  <pub-id pub-id-type="pmid">11869078</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <mixed-citation publication-type="other">Wojdasiewicz P, Poniatowski ŁA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm. 2014;2014.</mixed-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>John L</given-names>
                    </name>
                    <name>
                      <surname>Nagao</surname>
                      <given-names>Masashi</given-names>
                    </name>
                    <name>
                      <surname>Levine</surname>
                      <given-names>Brett R</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Di</given-names>
                    </name>
                    <name>
                      <surname>Olsen</surname>
                      <given-names>Bjorn R</given-names>
                    </name>
                    <name>
                      <surname>Im</surname>
                      <given-names>Hee-Jeong</given-names>
                    </name>
                  </person-group>
                  <article-title>Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain</article-title>
                  <source>Journal of Bone and Mineral Research</source>
                  <year>2016</year>
                  <volume>31</volume>
                  <issue>5</issue>
                  <fpage>911</fpage>
                  <lpage>924</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.2828</pub-id>
                  <pub-id pub-id-type="pmid">27163679</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mathiessen</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Conaghan</surname>
                      <given-names>PG</given-names>
                    </name>
                  </person-group>
                  <article-title>Synovitis in osteoarthritis: current understanding with therapeutic implications</article-title>
                  <source>Arthritis Res Ther</source>
                  <year>2017</year>
                  <volume>19</volume>
                  <issue>1</issue>
                  <fpage>18</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13075-017-1229-9</pub-id>
                  <pub-id pub-id-type="pmid">28148295</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yuan</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>An</surname>
                      <given-names>CH</given-names>
                    </name>
                  </person-group>
                  <article-title>Elevated VEGF levels contribute to the pathogenesis of osteoarthritis</article-title>
                  <source>BMC Musculoskelet Disord</source>
                  <year>2014</year>
                  <volume>15</volume>
                  <fpage>437</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2474-15-437</pub-id>
                  <pub-id pub-id-type="pmid">25515407</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
